These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 38193092)

  • 1. The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis.
    Emami Nejad A; Mostafavi Zadeh SM; Nickho H; Sadoogh Abbasian A; Forouzan A; Ahmadlou M; Nedaeinia R; Shaverdi S; Manian M
    Front Immunol; 2023; 14():1281567. PubMed ID: 38193092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA in multiple sclerosis.
    Gao Y; Han D; Feng J
    Clin Chim Acta; 2021 May; 516():92-99. PubMed ID: 33545109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
    Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S; Reddy PH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.
    Walsh AD; Nguyen LT; Binder MD
    ASN Neuro; 2021; 13():1759091420981182. PubMed ID: 33517686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust profiling of microRNAs and isomiRs in human plasma exosomes across 46 individuals.
    Karlsen TA; Aae TF; Brinchmann JE
    Sci Rep; 2019 Dec; 9(1):19999. PubMed ID: 31882820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Salivary miRNome: A Promising Biomarker of Disease.
    Tomei S; Manjunath HS; Murugesan S; Al Khodor S
    Microrna; 2021; 10(1):29-38. PubMed ID: 33845754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
    Piket E; Zheleznyakova GY; Kular L; Jagodic M
    J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as active players in the pathogenesis of multiple sclerosis.
    Fenoglio C; Ridolfi E; Galimberti D; Scarpini E
    Int J Mol Sci; 2012 Oct; 13(10):13227-39. PubMed ID: 23202949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MicroRNA in Body Fluids - Development of the Novel Plat Form for Cancer Therapeutics and Diagnosis].
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):899-905. PubMed ID: 30026410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.
    Manna I; Iaccino E; Dattilo V; Barone S; Vecchio E; Mimmi S; Filippelli E; Demonte G; Polidoro S; Granata A; Scannapieco S; Quinto I; Valentino P; Quattrone A
    FASEB J; 2018 Aug; 32(8):4241-4246. PubMed ID: 29505299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine.
    Záveský L; Slanař O
    Methods Mol Biol; 2023; 2630():135-143. PubMed ID: 36689181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and microRNA profiling of exosomes derived from blood and culture media.
    McDonald MK; Capasso KE; Ajit SK
    J Vis Exp; 2013 Jun; (76):e50294. PubMed ID: 23792786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRandola: extracellular circulating microRNAs database.
    Russo F; Di Bella S; Nigita G; Macca V; Laganà A; Giugno R; Pulvirenti A; Ferro A
    PLoS One; 2012; 7(10):e47786. PubMed ID: 23094086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs in multiple sclerosis: A clinical approach.
    Minutti-Zanella C; Bojalil-Álvarez L; García-Villaseñor E; López-Martínez B; Pérez-Turrent M; Murrieta-Álvarez I; Ruiz-Delgado GJ; Argüelles GJR
    Mult Scler Relat Disord; 2022 Jul; 63():103835. PubMed ID: 35533548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.
    Dolati S; Marofi F; Babaloo Z; Aghebati-Maleki L; Roshangar L; Ahmadi M; Rikhtegar R; Yousefi M
    Biomed Pharmacother; 2018 Aug; 104():280-290. PubMed ID: 29775896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in biofluids are novel tools for bladder cancer screening.
    Liu X; Liu X; Wu Y; Wu Q; Wang Q; Yang Z; Li L
    Oncotarget; 2017 May; 8(19):32370-32379. PubMed ID: 28423688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of microRNAs in multiple sclerosis.
    Junker A; Hohlfeld R; Meinl E
    Nat Rev Neurol; 2011 Jan; 7(1):56-9. PubMed ID: 21151203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.